HZNP:US has changed to a new ticker symbol.
Horizon Pharma, Inc., a biopharmaceutical company, develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. The companyÂ’s products include HZT-501, which completed Phase III clinical trials for the treatment of pain, osteoarthritis, and rheumatoid arthritis; LODOTRA that completed Phase III clinical trials for rheumatoid arthritis and is in Phase IIa clinical trials for asthma; TRUNOC, a Phase I clinical trials product targeting pain-related diseases; and HZN-602, a Phase I clinical trials product for the treatment of pain and arthritis. It has strategic partnerships or licensing agreements with Merck Serono; Mundipharma Medical Company; and SkyePharma and Jagotec AG. The company was founded in 2005 and is headquartered in Northbrook, Illinois.
Recent HZNP News from Yahoo Finance & Seeking Alpha
Rule 17(e) Announcement - Horizon Therapeutics plc »
DUBLIN, October 06, 2023-- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc) »
DUBLIN, October 03, 2023--IRISH TAKEOVER PANEL
Horizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023 »
DUBLIN, October 02, 2023--Horizon Therapeutics plc announces new UPLIZNA data in neuromyelitis optica spectrum disorder (NMOSD) to be presented at ECTRIMS 2023.
New Analysis Highlights Importance of Adhering to Uninterrupted Full Course of Treatment with TEPEZZA® (teprotumumab-trbw) to Support Thyroid Eye Disease (TED) Patient Outcomes »
DUBLIN, September 29, 2023--Horizon Therapeutics announced new data on TEPEZZA (teprotumumab-trbw) and Thyroid Eye Disease (TED) at American Thyroid Association (ATA) 2023.
Horizon Therapeutics plc Named to U.S. News & World Report’s 2024 List of Best Companies to Work For in the Health Care Industry »
DUBLIN, September 26, 2023--Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it has been named to U.S. News & World Report’s 2024 list of Best Companies to Work For in the Health Care Industry, ranking among the top companies recognized for employee wellbeing.
Older Archived News
- Strong On High Relative Volume: Horizon Pharma (HZNP).
- Trade-Ideas: Horizon Pharma (HZNP) Is Today's Strong On High Relative Volume Stock.
- Insider Trading Alert - BRT, TNAV And HZNP Traded By Insiders.
- Will Horizon Pharma (HZNP) Stock Be Helped By Earnings Beat?.
- Horizon Pharma (HZNP) Earnings Report: Q4 2015 Conference Call Transcript.
- Horizon Pharma (HZNP) In A Perilous Reversal.
- Today's Weak On High Volume Stock: Horizon Pharma (HZNP).
- Stock To Watch: Horizon Pharma (HZNP) In Perilous Reversal.
- Horizon Pharma (HZNP) Stock Gains on Raised Guidance.
- Horizon Pharma (HZNP) Is Today's Dead Cat Bounce Stock.Load More News...
